| Factor Information | |
|---|---|
| Data ID | 864 |
| Factor | Latest Echo--Systemic ventricle EF (%) |
| Description | At a mean 42-month echo follow-up, 91% of patients were free of significant SAVVR |
| Biomarker | NA |
| Classification | A7 (clinical factor - outcome) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | We assessed midterm outcomes and prognostic factors in ACHD undergoing SAVV surgery |
| p Value | <0.001 |
| Conclusion | Overall outcomes in this challenging population are good. The single factor associated with adverse events was predischarge SAVV regurgitation grade. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 486 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | AVSD/ccTGA/MS, MR |
| Reference | |
|---|---|
| PMID | 28520541 |
| Year | 2017 |
| Title | Outcomes and Prognostic Factors for Adult Patients With Congenital Heart Disease Undergoing Primary or Reoperative Systemic Atrioventricular Valve Surgery. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | retrospective cohort study | |
| Region | New York, USA | |
| Method | retrospective evaluation | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | SAVV surgery | |
| Group | ccTGA(Treatment) | Congenital MS/MR(Control) |
| Number | 14 | 14 |
| Age | 39.1 ± 15.4 years | 36.7 ± 11.4 years |
| Gender (Male: Female) | 7:7 (total) | 8:6 (total) |
| Marker Level | 37.7 ± 6.0 | 53.8 ± 7.9 |
